TREE NEWS update: Johnson & Johnson will acquire biopharmaceutical company Ollin Biosciences for up to $3.33 billion. The deal value was reported by Bloomberg. No further terms of the transaction were disclosed.
Johnson & Johnson to acquire Ollin Biosciences for up to $3.33B
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
20m ago
Global Markets: Nvidia Earnings Eve Sees Tech Stocks Slide, Nasdaq Futures Down 1.4%
54m ago
Chinese Listed Firms Address Nvidia Event Impact on Compute Supply Chains
58m ago
Bank of America CEO: Capital Markets Activity Has Been Very Volatile
1h ago
Strive buys 251 BTC for $17.5M, holdings reach 43,404 BTC
1h ago
XPeng Targets 100,000 Overseas Sales in 2026, Doubling in 2027
1h ago
Tom Lee: US Stocks May Rally as Core PCE Falls Toward 2%